Inventor · disambiguated record
Vito J. Palombella
Also filed as: PALOMBELLA VITO · PALOMBELLA VITO J
12 granted patents·8 pending applications·223 citations·filing 1994–2022
93Inventor score
Files withINFINITY PHARMACEUTICALS INC8MILLENNIUM PHARM INC3HARVARD COLLEGE2SANOFI AVENTIS DEUTSCHLAND2AVENTIS PHARMA GMBH1
Top patents by PatentIndex Score
20 records- 0194US9775844B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Oct 3, 2017·13 cites·48 claims
- 0294US9650441B2Anti-CD47 antibodies and methods of useERASMUS UNIV MEDICAL CENTER·Filed 2016·Granted May 16, 2017·19 cites·20 claims
- 0392US10675286B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Jun 9, 2020·4 cites·19 claims
- 0491US11541059B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2020·Granted Jan 3, 2023·2 cites·11 claims
- 0590US9527847B2Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitorsINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Dec 27, 2016·12 cites·35 claims
- 0689US8828998B2Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitorsINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Sep 9, 2014·11 cites·48 claims
- 0789US6627637B2Substituted beta carbolinesAVENTIS PHARMA GMBH·Filed 2001·Granted Sep 30, 2003·38 cites·38 claims
- 0885US7348336B2Substituted β-carbolinesSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted Mar 25, 2008·6 cites·22 claims
- 0980US6613541B1Method for monitoring proteasome inhibitor drug actionMILLENNIUM PHARM INC·Filed 1999·Granted Sep 2, 2003·68 cites·30 claims
- 1078US2024050437A1Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1177US6660268B1Proteasome regulation of NF-KB activityHARVARD COLLEGE·Filed 1994·Granted Dec 9, 2003·35 cites·3 claims
- 1276US7026331B2Substituted beta-carbolinesSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Apr 11, 2006·7 cites·22 claims
- 1376US6818427B1MEKK1 molecules and uses thereofMILLENNIUM PHARM INC·Filed 2000·Granted Nov 16, 2004·8 cites·20 claims
- 1459US2005084884A1MEKK1 molecules and uses thereofMILLENNIUM PHARM INC·Filed 2004·Application pending·0 cites
- 1553US2005037947A1Inhibition of drug binding to serum albuminFiled 2004·Application pending·0 cites
- 1652US2005281829A1Fc chimeric proteins with anti-HIV drugsHEHIR CRISTINA A T·Filed 2004·Application pending·0 cites
- 1751US2016022692A1Treatment of rheumatoid arthritis and asthma using pi3 kinase inhibitorsINFINITY PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1850US2014120060A1Treatment of rheumatoid arthritis and asthma using pi3 kinase inhibitorsINFINITY PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1946US2019062428A1Combination of anti-cd47 antibodies and cell death-inducing agents, and uses thereofSURFACE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 2046US2004097420A1Proteasome regulation of NF-kB activityHARVARD COLLEGE·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vito J. Palombella files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →